| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati Medical Center, Cincinnati, Ohio 45267
Correspondence: Address all correspondence and requests for reprints to: Dr. Nira Ben-Jonathan, Department of Cell Biology, 3125 Eden Avenue, University of Cincinnati, Cincinnati, Ohio 45267-0521. E-mail: Nira.Ben-Jonathan{at}uc.edu
Dopamine is a small and relatively simple molecule that fulfills diverse functions. Within the brain, it acts as a classical neurotransmitter whose attenuation or overactivity can result in disorders such as Parkinsons disease and schizophrenia. Major advances in the cloning and characterization of biosynthetic enzymes, transporters, and receptors have increased our knowledge regarding the metabolism, release, reuptake, and mechanism of action of dopamine. Dopamine reaches the pituitary via hypophysial portal blood from several hypothalamic nerve tracts that are regulated by PRL itself, estrogens, and several neuropeptides and neurotransmitters. Dopamine binds to type-2 dopamine receptors that are functionally linked to membrane channels and G proteins and suppresses the high intrinsic secretory activity of the pituitary lactotrophs. In addition to inhibiting PRL release by controlling calcium fluxes, dopamine activates several interacting intracellular signaling pathways and suppresses PRL gene expression and lactotroph proliferation. Thus, PRL homeostasis should be viewed in the context of a fine balance between the action of dopamine as an inhibitor and the many hypothalamic, systemic, and local factors acting as stimulators, none of which has yet emerged as a primary PRL releasing factor. The generation of transgenic animals with overexpressed or mutated genes expanded our understanding of dopamine-PRL interactions and the physiological consequences of their perturbations. PRL release in humans, which differs in many respects from that in laboratory animals, is affected by several drugs used in clinical practice. Hyperprolactinemia is a major neuroendocrine-related cause of reproductive disturbances in both men and women. The treatment of hyperprolactinemia has greatly benefited from the generation of progressively more effective and selective dopaminergic drugs.
This article has been cited by other articles:
![]() |
C. V. Helena, D. T. McKee, R. Bertram, A. M. Walker, and M. E. Freeman The Rhythmic Secretion of Mating-Induced Prolactin Secretion Is Controlled by Prolactin Acting Centrally Endocrinology, July 1, 2009; 150(7): 3245 - 3251. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ferone, F. Gatto, M. Arvigo, E. Resmini, M. Boschetti, C. Teti, D. Esposito, and F. Minuto The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology J. Mol. Endocrinol., May 1, 2009; 42(5): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kennett, M. O. Poletini, C. A. Fitch, and M. E. Freeman Antagonism of Oxytocin Prevents Suckling- and Estradiol-Induced, But Not Progesterone-Induced, Secretion of Prolactin Endocrinology, May 1, 2009; 150(5): 2292 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pasqualini, F.-A. Weltzien, B. Vidal, S. Baloche, C. Rouget, N. Gilles, D. Servent, P. Vernier, and S. Dufour Two Distinct Dopamine D2 Receptor Genes in the European Eel: Molecular Characterization, Tissue-Specific Transcription, and Regulation by Sex Steroids Endocrinology, March 1, 2009; 150(3): 1377 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nafisi, B. Banihashemi, M. Daigle, and P. R. Albert GAP1(IP4BP)/RASA3 Mediates G{alpha}i-induced Inhibition of Mitogen-activated Protein Kinase J. Biol. Chem., December 19, 2008; 283(51): 35908 - 35917. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liang, A. M. Shaw, M. Boules, S. Briody, J. Robinson, A. Oliveros, E. Blazar, K. Williams, Y. Zhang, P. R. Carlier, et al. Antidepressant-Like Pharmacological Profile of a Novel Triple Reuptake Inhibitor, (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS) J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 573 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Hugo, D. C. Borcherding, K. S. Gersin, J. Loftus, and N. Ben-Jonathan Prolactin Release by Adipose Explants, Primary Adipocytes, and LS14 Adipocytes J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4006 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, M. Nutu, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, E. Tallet, V. Goffin, C. Ling, and H. Billig Differences in Prolactin Receptor (PRLR) in Mouse and Human Fallopian Tubes: Evidence for Multiple Regulatory Mechanisms Controlling PRLR Isoform Expression in Mice Biol Reprod, October 1, 2008; 79(4): 748 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, S. Chen, J. Woodliff, and S. Kansra Curcumin (Diferuloylmethane) Inhibits Cell Proliferation, Induces Apoptosis, and Decreases Hormone Levels and Secretion in Pituitary Tumor Cells Endocrinology, August 1, 2008; 149(8): 4158 - 4167. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, T. Mitsui, M. Ishida, and J. Arita Adenovirus vectors differentially modulate proliferation of pituitary lactotrophs in primary culture in a mitogen and infection time-dependent manner J. Endocrinol., July 1, 2008; 198(1): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jimenez-Ortega, M. M. Masternak, J. A. Panici, Z. Wang, A. Bartke, and A. I. Esquifino Effects of Every-Other-Day Feeding on Prolactin Regulatory Mechanism in Transgenic Human Growth Hormone Mice Experimental Biology and Medicine, April 1, 2008; 233(4): 434 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bondioni, A. R. Angioni, S. Corbetta, M. Locatelli, S. Ferrero, E. Ferrante, G. Mantovani, L. Olgiati, P. Beck-Peccoz, A. Spada, et al. Effect of 9-cis Retinoic Acid on Dopamine D2 Receptor Expression in Pituitary Adenoma Cells Experimental Biology and Medicine, April 1, 2008; 233(4): 439 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways Endocrinology, April 1, 2008; 149(4): 1470 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu and L. A. Arbogast Phosphorylation State of Tyrosine Hydroxylase in the Stalk-Median Eminence Is Decreased by Progesterone in Cycling Female Rats Endocrinology, April 1, 2008; 149(4): 1462 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Khodr, S. M. Clark, D. L. Hurley, and C. J. Phelps Long-Term, Homologous Prolactin, Administered through Ectopic Pituitary Grafts, Induces Hypothalamic Dopamine Neuron Differentiation in Adult Snell Dwarf Mice Endocrinology, April 1, 2008; 149(4): 2010 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Millan, F. Loiseau, A. Dekeyne, A. Gobert, G. Flik, T. I. Cremers, J.-M. Rivet, D. Sicard, R. Billiras, and M. Brocco S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1212 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Holt Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists J Psychopharmacol, March 1, 2008; 22(2_suppl): 28 - 37. [Abstract] [PDF] |
||||
![]() |
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gruszka, S.-G. Ren, J. Dong, M. D. Culler, and S. Melmed Regulation of Growth Hormone and Prolactin Gene Expression and Secretion by Chimeric Somatostatin-Dopamine Molecules Endocrinology, December 1, 2007; 148(12): 6107 - 6114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishida, T. Mitsui, K. Yamakawa, N. Sugiyama, W. Takahashi, H. Shimura, T. Endo, T. Kobayashi, and J. Arita Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1529 - E1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Horner, Y. Cazals, R. Guieu, M. Lenoir, and N. Sauze Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1224 - E1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. McKee, M. O. Poletini, R. Bertram, and M. E. Freeman Oxytocin Action at the Lactotroph Is Required for Prolactin Surges in Cervically Stimulated Ovariectomized Rats Endocrinology, October 1, 2007; 148(10): 4649 - 4657. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tomei, A. Capozzella, M. Ciarrocca, P. Fiore, M. Valeria Rosati, M. Fiaschetti, T. Casale, V. Anzelmo, F. Tomei, and C. Monti Plasma dopamine in workers exposed to urban stressor Toxicology and Industrial Health, August 1, 2007; 23(7): 421 - 427. [Abstract] [PDF] |
||||
![]() |
A. Jaubert, G. Drutel, T. Leste-Lasserre, F. Ichas, and L. Bresson-Bepoldin Tyrosine Hydroxylase and Dopamine Transporter Expression in Lactotrophs from Postlactating Rats: Involvement in Dopamine-Induced Apoptosis Endocrinology, June 1, 2007; 148(6): 2698 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R Valdez, A. B Penissi, R. P Deis, and G. A Jahn Hormonal profile and reproductive performance in lactation deficient (OFA hr/hr) and normal (Sprague-Dawley) female rats Reproduction, April 1, 2007; 133(4): 827 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Zatelli, M. R. Ambrosio, M. Bondanelli, and E. C d. Uberti Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S29 - S35. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Dunlop and C. B. Nemeroff The Role of Dopamine in the Pathophysiology of Depression Arch Gen Psychiatry, March 1, 2007; 64(3): 327 - 337. [Full Text] [PDF] |
||||
![]() |
E. R. Samuels, R. H. Hou, R. W. Langley, E. Szabadi, and C. M. Bradshaw Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers J Psychopharmacol, November 1, 2006; 20(6): 756 - 770. [Abstract] [PDF] |
||||
![]() |
M. Chesterfield, J. Janik, E. Murphree, C. Lynn, E. Schmidt, and P. Callahan Orphanin FQ/Nociceptin Is a Physiological Regulator of Prolactin Secretion in Female Rats Endocrinology, November 1, 2006; 147(11): 5087 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Anderson, P. Beijer, A. S. Bang, M. A. Fenwick, S. J. Bunn, and D. R. Grattan Suppression of Prolactin-Induced Signal Transducer and Activator of Transcription 5b Signaling and Induction of Suppressors of Cytokine Signaling Messenger Ribonucleic Acid in the Hypothalamic Arcuate Nucleus of the Rat during Late Pregnancy and Lactation Endocrinology, October 1, 2006; 147(10): 4996 - 5005. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Garcia-Tornadu, M. Rubinstein, B. D Gaylinn, D. Hill, E. Arany, M. J Low, G. Diaz-Torga, and D. Becu-Villalobos GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin. J. Endocrinol., September 1, 2006; 190(3): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Guise, A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J.-J. Lebrun Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner Endocrinology, September 1, 2006; 147(9): 4351 - 4362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao Advances in the Treatment of Prolactinomas Endocr. Rev., August 1, 2006; 27(5): 485 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hnasko, F. A. Perez, A. D. Scouras, E. A. Stoll, S. D. Gale, S. Luquet, P. E. M. Phillips, E. J. Kremer, and R. D. Palmiter Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia PNAS, June 6, 2006; 103(23): 8858 - 8863. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-A. Weltzien, C. Pasqualini, M.-E. Sebert, B. Vidal, N. Le Belle, O. Kah, P. Vernier, and S. Dufour Androgen-Dependent Stimulation of Brain Dopaminergic Systems in the Female European Eel (Anguilla anguilla) Endocrinology, June 1, 2006; 147(6): 2964 - 2973. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Aiken, M. L. Looper, S. F. Tabler, D. K. Brauer, J. R. Strickland, and F. N. Schrick Influence of stocking rate and steroidal implants on growth rate of steers grazing toxic tall fescue and subsequent physiological responses J Anim Sci, June 1, 2006; 84(6): 1626 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sellix, M. Egli, M. O. Poletini, D. T. McKee, M. D. Bosworth, C. A. Fitch, and M. E. Freeman Anatomical and functional characterization of clock gene expression in neuroendocrine dopaminergic neurons Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1309 - R1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Angelier, C. Barbraud, H. Lormee, F. Prud'homme, and O. Chastel Kidnapping of chicks in emperor penguins: a hormonal by-product? J. Exp. Biol., April 15, 2006; 209(8): 1413 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-A. Liu, Q. Liu, K. Wawrowsky, Z. Yang, S. Lin, and S. Melmed Prolactin Receptor Signaling Mediates the Osmotic Response of Embryonic Zebrafish Lactotrophs Mol. Endocrinol., April 1, 2006; 20(4): 871 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. McArthur, Z.-L. Siddique, H. C. Christian, G. Capone, E. Theogaraj, C. D. John, S. F. Smith, J. F. Morris, J. C. Buckingham, and G. E. Gillies Perinatal Glucocorticoid Treatment Disrupts the Hypothalamo-Lactotroph Axis in Adult Female, But Not Male, Rats Endocrinology, April 1, 2006; 147(4): 1904 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Egli, R. Bertram, N. Toporikova, M. T. Sellix, W. Blanco, and M. E. Freeman Prolactin secretory rhythm of mated rats induced by a single injection of oxytocin Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E566 - E572. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bertram, M. Egli, N. Toporikova, and M. E. Freeman A mathematical model for the mating-induced prolactin rhythm of female rats Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E573 - E582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Anderson, J. L. Barclay, K. J. Fanning, D. H. L. Kusters, M. J. Waters, and J. D. Curlewis Mechanisms Underlying the Diminished Sensitivity to Prolactin Negative Feedback during Lactation: Reduced STAT5 Signaling and Up-Regulation of Cytokine-Inducible SH2 Domain-Containing Protein (CIS) Expression in Tuberoinfundibular Dopaminergic Neurons Endocrinology, March 1, 2006; 147(3): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, F. Roelfsema, J. G. Langendonk, C. C. de Wit, M. Frolich, J. Burggraaf, A. E. Meinders, and H. Pijl Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E218 - E224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bertram, J. Tabak, N. Toporikova, and M. E. Freeman Endothelin Action on Pituitary Lactotrophs: One Receptor, Many GTP-Binding Proteins Sci. Signal., January 24, 2006; 2006(319): pe4 - pe4. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tudpor, N. Charoenphandhu, W. Saengamnart, and N. Krishnamra Long-Term Prolactin Exposure Differentially Stimulated the Transcellular and Solvent Drag-Induced Calcium Transport in the Duodenum of Ovariectomized Rats Experimental Biology and Medicine, December 1, 2005; 230(11): 836 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, F. Roelfsema, M. Frolich, A. E. Meinders, and H. Pijl Spontaneous Diurnal Thyrotropin Secretion Is Enhanced in Proportion to Circulating Leptin in Obese Premenopausal Women J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6185 - 6191. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lin Chang, J. Roh, J.-I. Park, C. Klein, N. Cushman, R. V. Haberberger, and S. Y. T. Hsu Intermedin Functions as a Pituitary Paracrine Factor Regulating Prolactin Release Mol. Endocrinol., November 1, 2005; 19(11): 2824 - 2838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Andric, D. Zivadinovic, A. E. Gonzalez-Iglesias, A. Lachowicz, M. Tomic, and S. S. Stojilkovic Endothelin-induced, Long Lasting, and Ca2+ Influx-independent Blockade of Intrinsic Secretion in Pituitary Cells by Gz Subunits J. Biol. Chem., July 22, 2005; 280(29): 26896 - 26903. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ferraro, B. A. Eipper, and R. E. Mains Retrieval and Reuse of Pituitary Secretory Granule Proteins J. Biol. Chem., July 8, 2005; 280(27): 25424 - 25435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Liu, R. E. Baker, W. Chow, C. K. Sun, and H. P. Elsholtz Epigenetic Mechanisms in the Dopamine D2 Receptor-Dependent Inhibition of the Prolactin Gene Mol. Endocrinol., July 1, 2005; 19(7): 1904 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cristina, G. Diaz-Torga, A. Baldi, A. Gongora, M. Rubinstein, M. J. Low, and D. Becu-Villalobos Increased Pituitary Vascular Endothelial Growth Factor-A in Dopaminergic D2 Receptor Knockout Female Mice Endocrinology, July 1, 2005; 146(7): 2952 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Russell, E Murphree, J Janik, and P Callahan Effect of steroids and nitric oxide on pituitary hormone release in ovariectomized, peripubertal rats Reproduction, April 1, 2005; 129(4): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Phelps Postnatal Regression of Hypothalamic Dopaminergic Neurons in Prolactin-Deficient Snell Dwarf Mice Endocrinology, December 1, 2004; 145(12): 5656 - 5664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Smith Anterior pituitary hormones: development of a bioassay leading to the discovery of prolactin Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E813 - E814. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, F. Roelfsema, M. Frolich, A. E. Meinders, and H. Pijl Prolactin Release Is Enhanced in Proportion to Excess Visceral Fat in Obese Women J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4445 - 4449. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Marder, S. M. Essock, A. L. Miller, R. W. Buchanan, D. E. Casey, J. M. Davis, J. M. Kane, J. A. Lieberman, N. R. Schooler, N. Covell, et al. Physical Health Monitoring of Patients With Schizophrenia Am J Psychiatry, August 1, 2004; 161(8): 1334 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Gevry, F. L. Lopes, S. Ledoux, and B. D. Murphy Aberrant Intracellular Cholesterol Transport Disrupts Pituitary and Ovarian Function Mol. Endocrinol., July 1, 2004; 18(7): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Egli, R. Bertram, M. T. Sellix, and M. E. Freeman Rhythmic Secretion of Prolactin in Rats: Action of Oxytocin Coordinated by Vasoactive Intestinal Polypeptide of Suprachiasmatic Nucleus Origin Endocrinology, July 1, 2004; 145(7): 3386 - 3394. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chowanadisai, S. L. Kelleher, and B. Lonnerdal Maternal Zinc Deficiency Raises Plasma Prolactin Levels in Lactating Rats J. Nutr., June 1, 2004; 134(6): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Vitale and M. E. Carbajal Involvement of Myosin II in Dopamine-induced Reorganization of the Lactotroph Cell's Actin Cytoskeleton J. Histochem. Cytochem., April 1, 2004; 52(4): 517 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Mello, J. H. Mendelson, S. S. Negus, and M. Kelly Ovarian Steroid Hormone Modulation of the Acute Effects of Cocaine on Luteinizing Hormone and Prolactin Levels in Ovariectomized Rhesus Monkeys J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 156 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bigsby, A. Caperell-Grant, N. Berry, K. Nephew, and D. Lubahn Estrogen Induces a Systemic Growth Factor Through an Estrogen Receptor-Alpha-Dependent Mechanism Biol Reprod, January 1, 2004; 70(1): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Ren, S. Kim, J. Taylor, J. Dong, J.-P. Moreau, M. D. Culler, and S. Melmed Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5414 - 5421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Mendelson, M. B. Sholar, N. H. Mutschler, M. Jaszyna-Gasior, N. V. Goletiani, A. J. Siegel, and N. K. Mello Effects of Intravenous Cocaine and Cigarette Smoking on Luteinizing Hormone, Testosterone, and Prolactin in Men J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nybo, B. Nielsen, E. Blomstrand, K. Moller, and N. Secher Neurohumoral responses during prolonged exercise in humans J Appl Physiol, September 1, 2003; 95(3): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Damjanoska, N. A. Muma, Y. Zhang, D. N. D'Souza, F. Garcia, G. A. Carrasco, G. H. Kindel, K. A. Haskins, M. Shankaran, B. R. Petersen, et al. Neuroendocrine Evidence That (S)-2-(Chloro-5-fluoro-indol- l-yl)-1-methylethylamine Fumarate (Ro 60-0175) Is Not a Selective 5-Hydroxytryptamine2C Receptor Agonist J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zinger, M. McFarland, and N. Ben-Jonathan Prolactin Expression and Secretion by Human Breast Glandular and Adipose Tissue Explants J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 689 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Combs, A. H. Berg, M. W. Rajala, S. Klebanov, P. Iyengar, J. C. Jimenez-Chillaron, M. E. Patti, S. L. Klein, R. S. Weinstein, and P. E. Scherer Sexual Differentiation, Pregnancy, Calorie Restriction, and Aging Affect the Adipocyte-Specific Secretory Protein Adiponectin Diabetes, February 1, 2003; 52(2): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Hentges and M. J. Low Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice Endocrinology, December 1, 2002; 143(12): 4536 - 4543. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |